BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader

The three-day comprehensive audit covered the CDMO site's drug substance (DS) facility, drug product (DP) facility, QC laboratories, warehouse, and utiliti...

December 07, 2023 | News

GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant

Leading GMP cell CDMO I Peace, Inc. , specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that its&...

December 07, 2023 | News

Daewoong Pharmaceutical Received GMP Certification from Brazilian ANVISA

Daewoong Pharmaceutical, represented by CEO Seng-ho Jeon and Chang-Jae Lee, proudly announced that their Osong factory passed the Brazilian Good Manuf...

November 28, 2023 | News

Simcere and Connect ink exclusive deal for autoimmune drug Rademikibart.

Pursuant to the Agreement, Simcere obtains the exclusive rights in the development, manufacturing, and commercialization of Rademikibart for all indication...

November 24, 2023 | News

WuXi Biologics Achieves Breakthrough Productivity of ~6 g/L/day in Integrated Continuous Process at Pilot Scale

By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell culture...

November 23, 2023 | News

Merck Debuts ChemisTwin™: Digital Reference Materials Platform

Accelerates digitalization in labs and manufacturing by offering traceable digital records of physical reference materials Allows Pharma QC/QA and R&...

November 16, 2023 | News

In Conversation with Eugene Kang: Pioneering the Future of Cell Therapy with Thermo Fisher's CTS Detachable Dynabeads

In an exclusive Q&A by BioPharma APAC with Eugene Kang, Senior Product Manager for Cell Therapy at Thermo Fisher Scientific, we delve into the gr...

November 15, 2023 | News

Telix, an Australian Company, Announces Planned Acquisition of QSAM Biosciences and its Lead Therapy Candidate, CycloSam

CycloSam® is highly synergistic with Telix's existing therapeutic development activity in both prostate cancer and sarcoma. The proposed acquisiti...

November 14, 2023 | News

MasterControl's Manufacturing Excellence Surpasses 150 Customers Worldwide

MasterControl, a leading provider of quality management and next generation manufacturing execution software, announced a major milestone with over 150 cus...

November 13, 2023 | News

Cytiva and RoosterBio collaborate to address exosome manufacturing challenges

Aiming to improve exosome purification process that is currently slowing adoption of promising gene therapies and other new modalities A scalabl...

October 30, 2023 | News

HanAll, Daewoong, and NurrOn Launch Phase 1 Study for HL192

HanAll Biopharma and Daewoong Pharmaceutical marked a pivotal step forward in the development of HL192 (ATH-399A) for the potential treatment of Parkinso...

October 13, 2023 | News

GC Biopharma Signs Power Purchase Agreement with SK E&S

PPA is an electricity trading contract signed directly between a power generator and a customer company. Under this agreement, the company can purchase and...

October 11, 2023 | News

OBiO Launches GMP Facility Intelli-M for Rapid Delivery of Innovative Therapies

The launch of the new base in Shanghai will enhance OBiO's production and service capabilities in both China and the United States...

September 28, 2023 | News

Kivo launches unified platform offering best-in-class collaboration and compliance solution

Kivo GO is a new, unified platform for emerging life sciences companies who need to manage documents and processes across their Regulatory, Clinical and ...

September 27, 2023 | News

Stay Connected